Sildenafil Added to Pirfenidone in Patients with Advanced Idiopathic Pulmonary Fibrosis (IPF) and Risk of Pulmonary Hypertension (PH): Results of a Responder Analysis

被引：0
|
作者：
Harari, S. [1 ,2 ]
Nathan, S. D. [3 ]
Behr, J. [4 ]
Wuyts, W. A. [5 ]
Kirchgaessler, K. [6 ]
Bengus, M. [6 ]
Gilberg, F. [6 ]
Wells, A. U. [7 ]
机构：
[1] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy
[2] Osped San Giuseppe, Dept Med, Milan, Italy
[3] Inova Fairfax Hosp, Inova Heart & Vasc Inst, Falls Church, VA USA
[4] LMU & Asklepios Fachkliniken Gauting, Dept Internal Med, Comprehens Pneumol Ctr, Munich, Germany
[5] Univ Leuven, Dept Pulm Med, Unit Interstitial Lung Dis, Leuven, Belgium
[6] F Hoffmann Roche Ltd, Basel, Switzerland
[7] Royal Brompton Hosp, Interstitial Lung Dis Unit, London, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2434
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Sildenafil Added to Pirfenidone in Patients with Advanced Idiopathic Pulmonary Fibrosis (IPF) and Risk of Pulmonary Hypertension (PH)
    Behr, J.
    Nathan, S. D.
    Wuyts, W. A.
    Bishop, N.
    Bouros, D. E.
    Antoniou, K.
    Guiot, J.
    Kramer, M. R.
    Kirchgaessler, K.
    Bengus, M.
    Gilberg, F.
    Perjesi, A.
    Harari, S.
    Wells, A. U.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [2] Sildenafil Added to Pirfenidone in Patients with Advanced Idiopathic Pulmonary Fibrosis (IPF) and Risk of Pulmonary Hypertension (PH): Impact on Health-Related Quality of Life
    Wuyts, W. A.
    Nathan, S. D.
    Wells, A. U.
    Harari, S. A.
    Samara, K.
    Bengus, M.
    Gilberg, F.
    Behr, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [3] Sildenafil Added to Pirfenidone in Patients with Advanced Idiopathic Pulmonary Fibrosis (IPF) and Risk of Pulmonary Hypertension (PH): Analysis of PH Key Assessments (Right Heart Catheterization Availability and Baseline NT-proBNP)
    Behr, J.
    Nathan, S. D.
    Harari, S.
    Wuyts, W.
    Kirchgaessler, K.
    Bengus, M.
    Gilberg, F.
    Wells, A. U.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [4] Baseline Characteristics of All Patients Randomized in a Phase IIb Trial of Sildenafil Added to Pirfenidone in Patients with Advanced Idiopathic Pulmonary Fibrosis and Risk of Pulmonary Hypertension
    Behr, J.
    Nathan, S. D.
    Harari, S.
    Wuyts, W.
    Bishop, N. Mogulkoc
    Bouros, D. E.
    Antoniou, K.
    Guiot, J.
    Kramer, M.
    Kirchgaessler, K.
    Bengus, M.
    Gilberg, F.
    Wells, A. U.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [5] EFFICACY OF PIRFENIDONE ON DYSPNEA IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF): RESULTS FROM A POST HOC RESPONDER ANALYSIS
    Glassberg, Marilyn K.
    Thavarajah, Krishna
    Collins, Bridget F.
    Gupta, Sachin
    Trzaskoma, Benjamin
    Kirchgaessler, Klaus-Uwe
    Devine, Jacob
    Raghu, Ganesh
    CHEST, 2022, 162 (04) : 1246A - 1247A
  • [6] Long Term Safety and Survival in Patients with Advanced Idiopathic Pulmonary Fibrosis (IPF) and Risk of Pulmonary Hypertension (PH)
    Behr, J.
    Nathan, S. D.
    Harari, S.
    Wuyts, W.
    Kirchgaessler, K.
    Bengus, M.
    Gilberg, F.
    Alvaro, G.
    Wells, A. U.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [7] The Use Of Pirfenidone In Combination With Sildenafil For Advanced Idiopathic Pulmonary Fibrosis
    Riddell, P.
    Minnis, P.
    Egan, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [8] PULMONARY ARTERIAL-HYPERTENSION (PH) AND PULMONARY HEMODYNAMICS IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF)
    TANAKA, S
    NAGAI, S
    KITAICHI, M
    IZUMI, T
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A594 - A594
  • [9] Sildenafil decreases the contractile response to serotonin (5HT) pulmonary arteries from patients with idiopathic pulmonary fibrosis (IPF) and pulmonary hypertension (PH)
    Juan, Gustavo
    Milara, Javier
    Ortiz, Jose Luis
    Escriva, Juan
    Ramon, Mercedes
    Fernandez, Estrella
    Cortijo, Julio
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [10] Predictors of response to pirfenidone treatment in patients with idiopathic pulmonary fibrosis (IPF)
    Balestro, Elisabetta
    Turato, Graziella
    Biondini, Davide
    Pavanello, Sofia
    Fraccaro, Alessia
    Rigobello, Chiara
    Bazzan, Erica
    Campisi, Manuela
    Baraldo, Simonetta
    Cosio, Manuel
    Saetta, Marina
    Spagnolo, Paolo
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
12345